New studies reveal role of oxidative stress in diabetes
The world's leading redox scientists are heading to Boston to tackle the growing obesity and diabetes epidemics. Scientists will present the latest research and breakthroughs in an effort to better understand and treat those conditions, as well as the metabolic and cardiovascular complications associated with this exponentially expanding patient population.
"The mechanisms leading to Type 1 diabetes remain to be unraveled," said Desmond Schatz, MD, American Diabetes Association president-elect and Medical Director of the Diabetes Center at the University of Florida College of Medicine. "Whether damage and ultimate death of beta cells occurs before or after triggering of the auto immune response is the subject of intense debate. Unravelling the factors that lead to beta cell dysfunction in humans is key to ultimately deciphering the development of diabetes. Similarly the role of free radicals and mitochondrial dysfunction leading to insulin resistance in the genesis of Type 2 diabetes needs careful evaluation."
The discussions will take place on November 19th, during SFRBM 2015, the premier venue for cutting edge research in all aspects of redox biology, featuring the latest technologies and applications in basic science and how findings can enhance human health and well-being.
Redox scientists in all phases of their research careers – students and seasoned investigators alike – will be sharing their exciting and novel discoveries, which have relevant implications on health, medicine and everyday life. Keynote addresses, research presentations, workshops and professional development opportunities will emphasize scientific excellence at its highest levels.
SFRBM members are working on many areas critical to human health, including cancer, heart disease, aging, cardiovascular disease, obesity, diabetes and others.
About SFRBM
Founded in 1987, the Society for Redox Biology and Medicine (sfrbm.org) is an international organization of 1,200 scientists, investigators and clinicians who conduct research in the area of redox biology. These areas have shown explosive growth over the last decade and are now integral to major initiatives in basic, applied and translational research, including development of new therapies in cancer, heart disease, aging and cardiovascular disease.
Provided by Society for Redox Biology and Medicine